Literature DB >> 9636680

Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.

M C Villacres1, S Behboudi, T Nikkila, K Lovgren-Bengtsson, B Morein.   

Abstract

Exogenous nonreplicating antigens (Ag) incorporated into immunostimulating complexes (iscoms) induce CTL responses under MHC class I restriction. A requirement for inducing CTL responses is that the Ag is delivered to the cytosol of antigen-presenting cells (APC), a route restricted to endogenously produced Ag. To investigate the mechanisms by which iscoms elicit MHC class I-restricted responses, the intracellular distribution of influenza virus envelope proteins incorporated in iscoms (flu-iscoms) or in micelles (flumicelles) was studied in vitro using murine peritoneal cells (PEC). Ultrathin sections of cells pulsed with biotinylated flu-iscoms or flu-micelles were analyzed by electron microscopy after detection of the biotin label by reaction with streptavidin-gold. PEC pulsed with flu-iscoms showed a pattern of scattered gold particles distributed in clear and dense vesicles as well as in the intracellular space but not associated with organelles. In cells pulsed with flu-micelles, Ag was also detected in most cellular compartments but at a considerably lower concentration. The intracellular distribution of particulate Ag in iscom or micelle form was confirmed by lysis and differential centrifugation of Ag-pulsed APC. Furthermore, P815 cells pulsed with flu-iscoms were lysed by specific immune effectors showing that the iscom-Ag was processed and presented by class I-expressing APC. Flu-iscoms were internalized about 50-fold more efficiently than ovalbumin iscoms (ovaiscoms) suggesting that the nature of the protein and/or the presence of cellular receptors are important factors influencing the capacity of APC to take up iscom-borne proteins. PEC accounted for the most active internalization of iscom-borne Ag, although splenic dendritic cells and B cells also took up fluiscoms with remarkable efficiency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636680     DOI: 10.1006/cimm.1998.1278

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

Review 1.  Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines.

Authors:  Bassel Akache; Felicity C Stark; Gerard Agbayani; Tyler M Renner; Michael J McCluskie
Journal:  Methods Mol Biol       Date:  2022

2.  Induction of cell death by saponin and antigen delivery.

Authors:  Ching-An Wu; Ya-Wun Yang
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

3.  Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses.

Authors:  Gustaf Ahlén; Lena Strindelius; Tomas Johansson; Anki Nilsson; Nathalie Chatzissavidou; Magnus Sjöblom; Ulrika Rova; Jan Holgersson
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

Review 4.  A Systematic Review of Recent Advances in Equine Influenza Vaccination.

Authors:  Romain Paillot
Journal:  Vaccines (Basel)       Date:  2014-11-14

5.  Challenges in mucosal vaccination of cattle.

Authors:  P E Shewen; L Carrasco-Medina; B A McBey; D C Hodgins
Journal:  Vet Immunol Immunopathol       Date:  2008-10-17       Impact factor: 2.046

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.